PLUS1
13.475
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| SWK Holdings Corporation | SWKH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 13.475 | 0.00 | 0.00 | 0.00 | 13.475 | 07:00:33 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 13.00 | 22.00 | 9.00 | 40.91% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 13.475 | USD |
SWK Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 173.98M | 12.91M | 11.29M | $ 30.75M | $ 13.53M | 1.85 | 13.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 5.00 | 12.50% |
SWK News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/29/2020 | 16:08 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 5/19/2020 | 06:04 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 5/15/2020 | 17:18 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) |
| 5/15/2020 | 06:07 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 5/14/2020 | 16:07 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 5/14/2020 | 16:05 | PR Newswire (US) | SWK Holdings Corporation Announces Financial Results for.. |
| 5/04/2020 | 08:00 | PR Newswire (US) | Enteris BioPharma Appoints Rajiv Khosla, Ph.D., as Chief.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SWKH Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.94 | 13.99 | 12.93 | 13.60 | 24,788 | 0.535 | 4.13% |
| 1 Month | 12.00 | 13.99 | 11.75 | 13.12 | 12,201 | 1.48 | 12.29% |
| 3 Months | 14.00 | 14.00 | 6.12 | 12.34 | 6,222 | -0.525 | -3.75% |
| 6 Months | 14.00 | 14.20 | 6.12 | 12.77 | 5,750 | -0.525 | -3.75% |
| 1 Year | 14.00 | 14.20 | 6.12 | 12.77 | 5,750 | -0.525 | -3.75% |
| 3 Years | 14.00 | 14.20 | 6.12 | 12.77 | 5,750 | -0.525 | -3.75% |
| 5 Years | 14.00 | 14.20 | 6.12 | 12.77 | 5,750 | -0.525 | -3.75% |
SWK Description
| SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables; Pharmaceutical Development Services and others. It generates maximum revenue from the Finance Receivables segment. |
